Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-025119

Director sold 50,000 shares at an average $56.62 ($2,831,071)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessier-Lavigne Marc Director 2021-04-01 Sale −14,223 $55.61 $790,884 2,628,073 D
Tessier-Lavigne Marc Director 2021-04-01 Sale −29,593 $56.91 $1,684,019 2,598,480 D
Tessier-Lavigne Marc Director 2021-04-01 Sale −6,184 $57.60 $356,167 2,592,296 D
Open-market sales · 50,000 sh · avg $56.62 · $2,831,071
Loading xslF345X03/doc4.xml…